{"protocolSection":{"identificationModule":{"nctId":"NCT00227461","orgStudyIdInfo":{"id":"AMBarrett1"},"secondaryIdInfos":[{"id":"none applicable"}],"organization":{"fullName":"Kessler Foundation","class":"OTHER"},"briefTitle":"Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.","officialTitle":"Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients."},"statusModule":{"statusVerifiedDate":"2021-02","overallStatus":"UNKNOWN","lastKnownStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2005-09","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2021-12","type":"ESTIMATED"},"completionDateStruct":{"date":"2021-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2005-09-26","studyFirstSubmitQcDate":"2005-09-26","studyFirstPostDateStruct":{"date":"2005-09-28","type":"ESTIMATED"},"lastUpdateSubmitDate":"2021-02-16","lastUpdatePostDateStruct":{"date":"2021-02-17","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"A. M. Barrett, MD","investigatorTitle":"Director, Stroke Rehabilitation Research","investigatorAffiliation":"Kessler Foundation"},"leadSponsor":{"name":"Kessler Foundation","class":"OTHER"},"collaborators":[{"name":"UCB Pharma","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The study investigates the possibility that levetiracetam may improve the symptoms of chronic post-stroke aphasia.","detailedDescription":"In the study, 50 post-stroke subjects with aphasia will take levetiracetam and we will evaluate their speech, language, and memory in an ABAB design."},"conditionsModule":{"conditions":["Aphasia","Stroke"],"keywords":["Aphasia","Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"CROSSOVER","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":50,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Wait control","type":"OTHER","description":"Levitiracetam is started after a delay, with dosage and administration as described below.","interventionNames":["Drug: Levetiracetam first, then wait"]},{"label":"Treatment first","type":"EXPERIMENTAL","description":"Levitiracetam is started immediately after baseline data is collected; dosage and administration as described below.","interventionNames":["Drug: Wait first, then levetiracetam"]}],"interventions":[{"type":"DRUG","name":"Wait first, then levetiracetam","description":"Levetiracetam 250 mg orally twice daily for 7 days. This will increase to 500 mg oral twice daily for 7 days the following week. If this dose is tolerated, it will then be increased to 750 mg orally twice daily for another 7 days and then increased to 1000 mg orally twice daily for 7 days.","armGroupLabels":["Treatment first"],"otherNames":["Keppra"]},{"type":"DRUG","name":"Levetiracetam first, then wait","description":"subjects with aphasia will take levetiracetam and we will evaluate their speech, language, and memory in an ABAB design","armGroupLabels":["Wait control"],"otherNames":["Keppra"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Speech and language assessment","timeFrame":"6 months - 1year"}],"secondaryOutcomes":[{"measure":"Memory assessment","timeFrame":"6 months to 1 year"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Stroke\n* Aphasia\n* Can give consent\n\nExclusion Criteria:\n\n* Renal failure\n* Pregnancy\n* Other neurological condition","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"A.M. Barrett, MD","affiliation":"Kessler Foundation","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Kessler Foundation","city":"West Orange","state":"New Jersey","zip":"07052","country":"United States","geoPoint":{"lat":40.79871,"lon":-74.23904}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000001037","term":"Aphasia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000013064","term":"Speech Disorders"},{"id":"D000007806","term":"Language Disorders"},{"id":"D000003147","term":"Communication Disorders"},{"id":"D000019954","term":"Neurobehavioral Manifestations"},{"id":"D000009461","term":"Neurologic Manifestations"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M4042","name":"Aphasia","asFound":"Aphasia","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M15554","name":"Speech Disorders","relevance":"LOW"},{"id":"M10513","name":"Language Disorders","relevance":"LOW"},{"id":"M6064","name":"Communication Disorders","relevance":"LOW"},{"id":"M21516","name":"Neurobehavioral Manifestations","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"},{"id":"T1303","name":"Chronic Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000077287","term":"Levetiracetam"}],"ancestors":[{"id":"D000000927","term":"Anticonvulsants"},{"id":"D000018697","term":"Nootropic Agents"}],"browseLeaves":[{"id":"M1741","name":"Levetiracetam","asFound":"Headache","relevance":"HIGH"},{"id":"M3936","name":"Anticonvulsants","relevance":"LOW"},{"id":"M20464","name":"Nootropic Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"AntiConv","name":"Anticonvulsants"},{"abbrev":"NootAg","name":"Nootropic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}